In recent company developments, MAIA Biotechnology, Inc., a pharmaceutical preparations company valued at $54.93 million, has ...
MAIA Biotechnology, Inc. (NYSEAMERICAN: MAIA) disclosed information relating to its Phase 2 THIO-101 trial in advanced non-small cell lung cancer through a press release on February 4, 2025. According ...
A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC ...
TikTok has been sued by the parents of four British teenagers who believe the children died after taking part in viral trends ...
MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) recently disclosed updates to the employment agreements of key executive officers in a Form 8-K filing dated February 1, 2025. The company entered into ...
Launched by homegrown real estate portal MOGUL.sg, MAIA is a virtual property assistant designed to streamline property searches, schedule viewings, and eliminate unnecessary agent commissions.
The lawsuit claims the four children all died while attempting the so-called "blackout challenge". | ITV National News ...
Maia, as the AI bot is called, is the first of its kind in Singapore and takes only a 0.2% commission. Read more at ...
Malay Mail on MSN1d
AI takes over: Singapore’s new property agent isn’t humanSINGAPORE, Feb 6 — Home buyers in Singapore may soon rely on artificial intelligence rather than human agents to find their ...
MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback